FDA Archives - Page 2 of 9 - Partnership to End Addiction

Internet Companies Must Do More to Shut Down Illegal Opioid Sales: FDA

This week, Food and Drug Administration Commissioner Scott Gottlieb said large Internet companies must do more to prevent illegal online opioid sales, according to The Wall Street Journal.

Naloxone Recalled Because of Particulate Matter on Syringe Plunger

The opioid overdose antidote naloxone has been recalled by its manufacturer because of loose particulate matter on the syringe plunger, CNN reports.

FDA Commissioner: Tobacco Companies Need to Stop Kids From Vaping

Food and Drug Administration Commissioner Scott Gottlieb said this week that tobacco companies need to speed up their efforts to stop kids from using e-cigarettes.

Regulators Tell E-Liquid Companies to Make Packaging Less Appealing to Kids

The Food and Drug Administration and the Federal Trade Commission has warned companies that make and sell e-cigarette liquids to make their packaging less appealing to children.

FDA Will Crack Down on Companies Marketing Vaping Products to Children

The Food and Drug Administration will be taking enforcement actions to target companies that are marketing vaping products in ways that are deliberately appealing to children, the agency’s commissioner told CNN.

FDA Calls on Online Companies to Police Opioid Sales

Food and Drug Administration Commissioner Scott Gottlieb this week called on Internet service providers and social media companies to more carefully monitor online sales of opioids.

FDA to Host Meeting on Patient-Focused Drug Development for Opioid Use Disorder

The Food and Drug Administration will host a public meeting April 17 on patient-focused drug development for opioid use disorder, in collaboration with the National Institute on Drug Abuse.

FDA to Allow Drug Companies to Sell Wider Range of Opioid Addiction Treatments

The Food and Drug Administration will allow drug companies to sell medications that reduce opioid cravings, even if they do not fully stop addiction, The New York Times reports.

FDA Announces Voluntary Destruction and Recall of Kratom Products

The Food and Drug Administration this week announced it is overseeing the voluntary destruction and recall of kratom products.

FDA Calls Kratom An Opioid

The Food and Drug Administration is warning that the supplement known as “kratom” is an opioid and has been linked with 44 deaths, The Washington Post reports.

FDA Asks Makers of Anti-Diarrhea Drug to Change Packaging to Curb Abuse

The Food and Drug Administration this week asked the makers of the over-the-counter anti-diarrhea drug loperamide (Imodium A-D) to change the way they package their products, in an effort to reduce abuse.

FDA Sends Warning to Distributors of Snortable Chocolate Powder Called “Coco Loko”

The Food and Drug Administration has sent a warning letter to the marketers and distributors of a snortable chocolate powder called “Coco Loko,” for selling unapproved new drugs and misbranded drugs.

FDA Issues Advisory About Deadly Risks Associated With Herb Kratom

The Food and Drug Administration advised consumers to avoid using the herb kratom, citing 36 known deaths associated with products containing the substance.

FDA Encourages Use of Medication-Assisted Treatment for Opioid Addiction

The Food and Drug Administration will encourage widespread use of medication-assisted treatment for opioid addiction, the agency’s commissioner said Wednesday.

FDA: Don’t Mix Opioid Addiction Medication With Anti-Anxiety Drugs

The Food and Drug Administration issued a new warning this week about mixing medication to treat opioid addiction with anti-anxiety drugs. Both types of drugs slow breathing and brain activity.

FDA Approves Marketing of First Mobile App to Help Treat Substance Use Disorders

The Food and Drug Administration has permitted marketing of the first mobile app to help treat substance use disorders. The app is designed to be prescribed by a doctor and used along with counseling, CNBC reports.

Poison Control Center Calls Involving Dietary Supplements on the Rise

Calls to poison control centers regarding dietary supplements increased by almost 50 percent between 2005 and 2012, according to a new study. A majority of the calls involved children 6 years old and under.

Weakening FDA’s Authority Over Tobacco Could Impact Use, Advocates Say

Weakening the Food and Drug Administration’s regulatory authority over tobacco could have an adverse impact on tobacco use, according to advocacy groups.

FDA Workshop Will Consider Hazards of Exploding E-Cigarette Batteries

The Food and Drug Administration will hold a workshop in April to consider the hazards of exploding batteries in e-cigarettes, HealthDay reports.

App That Alerts Naloxone Carriers to Nearby Overdoses Wins FDA Contest

An app that alerts people carrying the opioid overdose antidote naloxone to someone nearby who has overdosed is the winner of a competition created by the Food and Drug Administration.

Prescriber Education Campaign Helps Address National Opioid Epidemic

Prescribers have a vital role to play in reducing Americans’ misuse of prescription medications, especially opioids, which is why the resources provided via “Search and Rescue” are such an important part of a comprehensive solution.

FDA Considers Whether Naloxone Devices Should Contain Standard Dose of Drug

The Food and Drug Administration will determine whether naloxone devices distributed in communities should contain a standard dose of the opioid overdose antidote, according to U.S. News & World Report.

FDA Looking for Apps to Combat Opioid Overdose

The Food and Drug Administration this week launched the 2016 Naloxone App Competition to look for innovative technologies to fight the opioid epidemic.

FDA Issues Warning Letters to Websites, Stores Selling E-Cigarettes to Minors

The Food and Drug Administration has issued warning letters to 24 websites for illegally selling e-cigarettes to minors, The Wall Street Journal reports. The agency banned e-cigarette sales to anyone under 18 years old earlier this year.

Two Advisory Panels Recommend Removing Warning from Smoking Cessation Pill

Two advisory panels to the U.S. Food and Drug Administration this week recommended removing warnings about suicide from the smoking cessation pill Chantix, according to The Wall Street Journal.

previous 1 2 3 4 … 9 next